Mirum Pharmaceuticals, Inc.
MIRM
Classifica tra le azioni
#3277
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Prezzo delle azioni
$82.58
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$5.36B
Variazione (1 giorno)
3.05%
Variazione (1 anno)
13.08%
Paese
US
Scambia Mirum Pharmaceuticals, Inc. (MIRM)
Categoria
Healthcare
Storico del rendimento da dividendi per Mirum Pharmaceuticals, Inc. (MIRM)
Il rendimento da dividendi (TTM) di Mirum Pharmaceuticals, Inc. (simbolo azionario: MIRM) al 2023-12-31 è: 0.00%
Rendimento medio negli ultimi 5 anni: 0.00%
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Mirum Pharmaceuticals, Inc. (MIRM) da 2018 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
| Anno | Rendimento da dividendi | Cambia |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
| Azienda | Rendimento da dividendi | Il paese |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
